Janus Henderson Group PLC Mirum Pharmaceuticals, Inc. Transaction History
Janus Henderson Group PLC
- $207 Billion
- Q3 2025
A detailed history of Janus Henderson Group PLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,997,586 shares of MIRM stock, worth $357 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
4,997,586
Previous 5,236,277
4.56%
Holding current value
$357 Million
Previous $266 Million
37.49%
% of portfolio
0.18%
Previous 0.14%
Shares
11 transactions
Others Institutions Holding MIRM
# of Institutions
291Shares Held
57.5MCall Options Held
86.1KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$485 Million21.07% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$231 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$182 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.52MShares$180 Million3.41% of portfolio
-
Bvf Inc San Francisco, CA1.5MShares$107 Million5.93% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.63B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...